Exact Mass: 262.1681
Exact Mass Matches: 262.1681
Found 185 metabolites which its exact mass value is equals to given mass value 262.1681,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glyceryl 5-hydroxydecanoate
Glyceryl 5-hydroxydecanoate is used as a food additive [EAFUS] ("EAFUS: Everything Added to Food in the United States. [http://www.eafus.com/]") It is used as a food additive .
Mepindolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
1ST169198
Matridin-15-one, 13,14-didehydro-, 1-oxide is a natural product found in Sophora viciifolia, Sophora alopecuroides, and other organisms with data available. Oxysophocarpine is an alkaloid extracted from Sophora alopecuroides.?Oxysophocarpine has neuroprotective and anti-nociceptive effects on the central and peripheral nervous systems[1]. Oxysophocarpine inhibits the?growth?and?metastasis?of ?oral?squamous?cell?carcinoma?(OSCC)[2]. Oxysophocarpine is an alkaloid extracted from Sophora alopecuroides.?Oxysophocarpine has neuroprotective and anti-nociceptive effects on the central and peripheral nervous systems[1]. Oxysophocarpine inhibits the?growth?and?metastasis?of ?oral?squamous?cell?carcinoma?(OSCC)[2].
Oxysophocarpine
Oxysophocarpine is an alkaloid extracted from Sophora alopecuroides.?Oxysophocarpine has neuroprotective and anti-nociceptive effects on the central and peripheral nervous systems[1]. Oxysophocarpine inhibits the?growth?and?metastasis?of ?oral?squamous?cell?carcinoma?(OSCC)[2]. Oxysophocarpine is an alkaloid extracted from Sophora alopecuroides.?Oxysophocarpine has neuroprotective and anti-nociceptive effects on the central and peripheral nervous systems[1]. Oxysophocarpine inhibits the?growth?and?metastasis?of ?oral?squamous?cell?carcinoma?(OSCC)[2].
11-Oxo-tetrahydro-rhombifolin|3-but-3-enyl-octahydro-1,5-methano-pyrido[1,2-a][1,5]diazocine-4,6-dione
tert-butyl 3-(2-aminophenyl)pyrrolidine-1-carboxylate
4-Boc-9-Methyl-2,3,4,5-tetrahydro-1hbenzo[e][1,4]diazepine
4-Boc-7-Methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine
ETHYL 1-(2-(AMINOMETHYL)PHENYL)PIPERIDINE-4-CARBOXYLATE
TERT-BUTYL 3-(PHENYLAMINO)PYRROLIDINE-1-CARBOXYLATE
Carbamic acid, N-(4-phenyl-3-pyrrolidinyl)-, 1,1-dimethylethyl ester
4-(4-hydroxy-piperidine-1-ylmethyl)-benzimidic acid ethyl ester
2-(4-methoxy-2,3-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
1-PIPERAZINECARBOXYLIC ACID, 4-(3-PYRIDINYL)-, 1,1-DIMETHYLETHYL ESTER
3-(4-BENZYL-PIPERAZIN-1-YL)-PROPIONIC ACID METHYL ESTER
2-(3-Ethoxy-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
3-(4-HYDROXY-PIPERIDIN-1-YLMETHYL)-BENZIMIDIC ACID ETHYL ESTER
trans-(4-Amino-1-benzylpyrrolidin-3-yl)-acetic acid ethyl ester
tert-Butyl(3S,4R)-4-phenylpyrrolidin-3-ylcarbamate
tert-Butyl 3-(4-aminophenyl)pyrrolidine-1-carboxylate
4,4,5,5-tetramethyl-2-(3-phenoxypropyl)-1,3,2-dioxaborolane
3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-propan-1-ol
2-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PROPYL)PHENOL
3-(2-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
4-(4-Pyridinyl)-1-piperidinecarboxylic acid 1,1-dimethylethyl ester
1-(2,3-DIHYDRO-1H-INDEN-2-YL)HYDRAZINEHYDROCHLORIDE
1-(2-ethylhexyl)-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile
2-(4-HYDROXY-PIPERIDIN-1-YLMETHYL)-BENZIMIDIC ACID ETHYL ESTER
6-Aminomethyl-3,4-dihydro-1H-isoquinoline-2-carboxylicacid tert-butyl ester
3,4,5,6-tetrahydro-2H-[2,4-bipyridine]-1-carboxylic acid tert-butyl ester
5-AMINO-2,3,4,5-TETRAHYDRO-BENZO[B]AZEPINE-1-CARBOXYLICACIDTERT-BUTYLESTER
Mixidine
C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent
7-aminomethyl-2-Boc-1,2,3,4-tetrahydroisoquinoline
tert-butyl 1-(aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carboxylate
2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-(3-Methoxy-4,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(1,1-DIOXO-2,3-DIHYDRO-1H-1LAMBDA6-THIOPHEN-3-YLAMINO)-ACETICACID
2-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-2-ol
Benzyl 4-((methylamino)methyl)piperidine-1-carboxylate
[(2R)-3-carboxy-2-[(3-hydroxypentanoyl)oxy]propyl]trimethylazanium
Mepindolol
C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AA - Beta blocking agents, non-selective C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
[3-Carboxy-2-(3-hydroxy-3-methylbutanoyl)oxypropyl]-trimethylazanium
(1R,9S,12S)-12-hydroxy-7,15-diazatetracyclo[7.7.1.02,7.010,15]heptadec-5-en-4-one
[3-Carboxy-2-(3-hydroxy-2-methylbutanoyl)oxypropyl]-trimethylazanium
[(2R)-3-carboxy-2-(3-hydroxy-3-methylbutanoyl)oxypropyl]-trimethylazanium
[3-Carboxy-2-hydroxy-2-(3-methylbutanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(5-hydroxypentanoyloxy)propyl]-trimethylazanium
[3-Carboxy-2-(3-hydroxypentanoyloxy)propyl]-trimethylazanium
[(2S)-3-carboxy-2-(3-hydroxypentanoyloxy)propyl]-trimethylazanium
[(2R)-3-carboxy-2-[(2R)-2-hydroxy-3-methylbutanoyl]oxypropyl]-trimethylazanium
[3-Carboxy-2-(4-hydroxypentanoyloxy)propyl]-trimethylazanium
N-cyclohexyl-5,6,7,8-tetrahydro-4H-cyclohepta[d]isoxazole-3-carboxamide
[2-(Carboxymethyl)-1,2-dihydroxy-5-methyl-3-oxohexyl]-trimethylazanium
[(2R)-3-carboxy-2-(2-hydroxypentanoyloxy)propyl]-trimethylazanium
4-Methoxy-2-methyl-3-[(trimethylsilyl)methyl]-3-phenyl-1-butene
12-oxo-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-13-en-7-ium-7-olate
(1r,2r,9s)-11-(but-3-en-1-yl)-7,11-diazatricyclo[7.3.1.0²,⁷]tridecane-8,10-dione
9-hydroxy-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-6-one
15-hydroxy-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-6-one
(4r,9r,17r)-4-hydroxy-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-1-en-6-one
12-hydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-en-4-one
(9s,17s)-6-oxo-7,13-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-1-en-13-ium-13-olate
(1s,6s,9r,10s)-6-hydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-2-en-8-one
12-hydroxy-7,15-diazatetracyclo[7.7.1.0²,⁷.0¹⁰,¹⁵]heptadec-5-en-4-one
(?)-12β-hydroxylsophocarpine
{"Ingredient_id": "HBIN000758","Ingredient_name": "(?)-12\u03b2-hydroxylsophocarpine","Alias": "NA","Ingredient_formula": "C15H22N2O2","Ingredient_Smile": "C1CC2CN3C(C4C2N(C1)CCC4)C(C=CC3=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10336","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
17-oxo-lupanine
{"Ingredient_id": "HBIN002066","Ingredient_name": "17-oxo-lupanine","Alias": "NA","Ingredient_formula": "C15H22N2O2","Ingredient_Smile": "C1CCN2C(C1)C3CC(C2=O)C4CCCC(=O)N4C3","Ingredient_weight": "262.35 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "16243","PubChem_id": "14139904","DrugBank_id": "NA"}
(?)-9α-hydroxylsophocarpine
{"Ingredient_id": "HBIN014052","Ingredient_name": "(?)-9\u03b1-hydroxylsophocarpine","Alias": "NA","Ingredient_formula": "C15H22N2O2","Ingredient_Smile": "C1CC2CN3C(CC=CC3=O)C4C2N(C1)CC(C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10335","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(- )-9α-hydroxysophocarpine
{"Ingredient_id": "HBIN014054","Ingredient_name": "(- )-9\u03b1-hydroxysophocarpine","Alias": "NA","Ingredient_formula": "C15H22N2O2","Ingredient_Smile": "C1CC2CN3C(CC=CC3=O)C4C2N(C1)CC(C4)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37020","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
